ArticleFrontiers in human neuroscience2026
Reduced cortical brain perfusion following COVID-19 infection: impact of COVID-19 severity and relation to memory performance.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Changes to brain perfusion may be contributing to long-term cognitive dysfunction following COVID-19 infection. Lower brain perfusion beyond the acute phase of infection, as measured by perfusion MRI, has been observed in both hospitalized and non-hospitalized cases. Additionally, the hippocampus has been previously shown to be particularly sensitive to changes in blood flow. Therefore, the hippocampus may be vulnerable to perfusion changes associated with COVID-19, leading to long-term cognitive sequalae. The literature suggest that this may be particularly true among those with severe respiratory symptoms. However, the relationship between COVID-19 respiratory severity, perfusion, and cognitive dysfunction has yet to be thoroughly explored, especially after longer recovery times. Methods: Seventy-eight participants completed a neuroimaging session and two memory tests, the Mnemonic Similarity Task (MST) and Face-Name Associative Memory Exam (FNAME), tasks known to be mediated by the hippocampus. Participants were divided into four groups based on the severity of self-reported respiratory symptoms experienced during the acute infection: controls without a reported diagnosis of COVID-19, those with COVID-19 and without respiratory symptoms, those with COVID-19 and respiratory symptoms, and hospitalized participants with respiratory symptoms from COVID-19. On average, participants were 13 months from initial infection. Perfusion was measured with pseudo-continuous arterial spin labeled (pCASL) MRI. Total cortical gray and white matter perfusion, as well as gray matter perfusion in the territories of the anterior, middle, and posterior cerebral arteries were obtained using a mask adapted from previous studies. Results: The hospitalized group demonstrated lower total gray matter cortical perfusion compared to all groups, Discussion: Results provide evidence for global perfusion dysfunction among hospitalized participants with severe respiratory symptoms that persists for more than a year after COVID-19 infection. Additionally, there was a relationship between perfusion and pattern separation performance among all participants, suggesting that poorer perfusion may underlie some of the long-term COVID-19 cognitive symptoms.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.